GENB
Generate Biomedicines, Inc.
13.49
-0.29 (-2.10%)
52w low 11.00
22.67 high
21.3% of range
Financial Analysis
| (USD) | Mar 26 | Jun 26 | Trend |
|---|---|---|---|
| Cash & Equivalents | 160.57M | 135.36M | |
| Current Assets | 535.39M | 470.25M | |
| Net PP&E | 85.60M | 82.38M | |
| Total Assets | 625.74M | 561.69M | |
| Current Liabilities | 58.39M | 56.64M | |
| Total Debt | 65.57M | 62.63M | |
| Total Liabilities | 110.94M | 105.64M | |
| Retained Earnings | -737.74M | -804.99M | |
| Shareholders Equity | 514.80M | 456.05M | |
| Working Capital | 477.00M | 413.62M | |
| Shares Outstanding | 128.19M | 128.27M |
Revenue CAGR
-10.5%
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
-12.6%